Ticker XLRN – Acceleron P – sales, description, marketcap – Tickerday.com

XLRN

Acceleron P

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 6.81B; Volume: 73.67K; AvgVol 3m: 578.56K; Beta: 0.59;

Cost estimate:

P/E: –; EPS: -2.60; EPS growth quarter/prev quarter: -1.10%;

EPS growth this year: 8.10%; EPS growth past 5 years: -7.90%;

EPS ttm: -2.60;

P/S: 80.50; P/B: 13.98; P/Cashflow: 18.09; P/FCF: ;

Sales: 87.64M; Sales growth quarter/prev quarter: 43.70%; Sales growth past 5 years: 38.30%;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -28.10%; ROE – return on equity: -31.60%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 0.20%; Insider Transactions:-18.58%;

Institutional Ownership: 80.30%; Institutional Transactions: -0.94%;

Data update: 07.10.2020.